Syk Activation in Circulating and Tissue Innate Immune Cells in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

Objective Syk is a cytoplasmic protein tyrosine kinase that plays a role in signaling via B cell and Fc receptors (FcR). FcR engagement and signaling via Syk is thought to be important in antineutrophil cytoplasm antibody (ANCA) IgG–mediated neutrophil activation. This study was undertaken to invest...

Full description

Saved in:
Bibliographic Details
Published inArthritis & rheumatology (Hoboken, N.J.) Vol. 75; no. 1; pp. 84 - 97
Main Authors Prendecki, Maria, Gulati, Kavita, Pisacano, Noelle, Pinheiro, Damilola, Bhatt, Tejal, Mawhin, Marie‐Anne, Toulza, Frederic, Masuda, Esteban S., Cowburn, Andrew, Lodge, Katharine M., Tam, Frederick W. K., Roufosse, Candice, Pusey, Charles D., McAdoo, Stephen P.
Format Journal Article
LanguageEnglish
Published Boston, USA Wiley Periodicals, Inc 01.01.2023
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN2326-5191
2326-5205
2326-5205
DOI10.1002/art.42321

Cover

More Information
Summary:Objective Syk is a cytoplasmic protein tyrosine kinase that plays a role in signaling via B cell and Fc receptors (FcR). FcR engagement and signaling via Syk is thought to be important in antineutrophil cytoplasm antibody (ANCA) IgG–mediated neutrophil activation. This study was undertaken to investigate the role of Syk in ANCA‐induced myeloid cell activation and vasculitis pathogenesis. Methods Phosphorylation of Syk in myeloid cells from healthy controls and ANCA‐associated vasculitis (AAV) patients was analyzed using flow cytometry. The effect of Syk inhibition on myeloperoxidase (MPO)–ANCA IgG activation of cells was investigated using functional assays (interleukin‐8 and reactive oxygen species production) and targeted gene analysis with NanoString. Total and phosphorylated Syk at sites of tissue inflammation in patients with AAV was assessed using immunohistochemistry and RNAscope in situ hybridization. Results We identified increased phosphorylated Syk at critical activatory tyrosine residues in blood neutrophils and monocytes from patients with active AAV compared to patients with disease in remission or healthy controls. Syk was phosphorylated in vitro following MPO‐ANCA IgG stimulation, and Syk inhibition was able to prevent ANCA‐mediated cellular responses. Using targeted gene expression analysis, we identified up‐regulation of FcR‐ and Syk‐dependent signaling pathways following MPO‐ANCA IgG stimulation. Finally, we showed that Syk is expressed and phosphorylated in tissue leukocytes at sites of organ inflammation in AAV. Conclusion These findings indicate that Syk plays a critical role in MPO‐ANCA IgG–induced myeloid cell responses and that Syk is activated in circulating immune cells and tissue immune cells in AAV; therefore, Syk inhibition may be a potential therapeutic option.
Bibliography:Supported by the NIHR Imperial Biomedical Research Centre. Dr. Prendecki's work was supported by the Academy of Medical Sciences (grant SGL023/1071) and by an NIHR Clinical Lectureship. Dr. Tam's work was supported by the Ken and Mary Minton Chair of Renal Medicine. Dr. McAdoo's work was supported by Vasculitis UK and by an Imperial College Wellcome Trust ISSF Fellowship.
https://onlinelibrary.wiley.com/action/downloadSupplement?doi=10.1002%2Fart.42321&file=art42321‐sup‐0001‐Disclosureform.pdf
Presented in abstract form at the 19th International Vasculitis and ANCA Workshop in Philadelphia, PA, in April 2019
.
Author disclosures are available at
https://doi.org/10.1093/rheumatology/kez061.027
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Author disclosures are available at https://onlinelibrary.wiley.com/action/downloadSupplement?doi=10.1002%2Fart.42321&file=art42321‐sup‐0001‐Disclosureform.pdf.
Presented in abstract form at the 19th International Vasculitis and ANCA Workshop in Philadelphia, PA, in April 2019 (https://doi.org/10.1093/rheumatology/kez061.027).
ISSN:2326-5191
2326-5205
2326-5205
DOI:10.1002/art.42321